Humana Inc. (HUM) – What Are Investment Firms Saying About This Stock?

Shares of Humana Inc. (NYSE:HUM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the thirty-three ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, seven have issued a hold rating, twenty-three have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $484.78.

Several equities research analysts have weighed in on HUM shares. Lake Street Capital initiated coverage on Humana in a research note on Thursday, July 30th. They set a “buy” rating on the stock. TD Cowen upgraded Humana from a “hold” rating to a “buy” rating in a research report on Monday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Humana in a research note on Thursday, November 12th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $515.00 price objective on shares of Humana in a research note on Tuesday. Finally, ThinkEquity started coverage on Humana in a report on Monday. They issued a “buy” rating for the company.

Check Out Our Latest Analysis on HUM

Key Headlines Impacting Humana

These are some of the HUM headlines that stood out recently:

Insider Transactions at Humana

In other Humana news, insider Joseph Ventura sold 5,495 shares of Humana stock in a transaction on Monday, November 9th. The shares were sold at an average price of $433.85, for a total transaction of $2,384,005.75. Following the completion of the transaction, the insider directly owned 21,910 shares of the company’s stock, valued at $9,505,653.50. The trade was a 20.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Humana

Several hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. bought a new position in Humana during the 2nd quarter worth about $4,138,160,000. State Street Corp raised its holdings in shares of Humana by 1.6% in the 3rd quarter. State Street Corp now owns 5,543,942 shares of the insurance provider’s stock valued at $2,115,402,000 after purchasing an additional 86,870 shares in the last quarter. Pzena Investment Management LLC bought a new stake in shares of Humana in the 2nd quarter valued at about $1,749,014,000. Assenagon Asset Management S.A. raised its holdings in shares of Humana by 20,126.8% in the 3rd quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider’s stock valued at $479,053,000 after purchasing an additional 1,249,272 shares in the last quarter. Finally, Legal & General Group Plc purchased a new stake in shares of Humana in the 2nd quarter worth approximately $329,760,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of NYSE:HUM opened at $442.84 on Wednesday. The firm has a fifty day simple moving average of $410.55 and a two-hundred day simple moving average of $319.48. Humana has a 52 week low of $163.11 and a 52 week high of $462.87. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $53.19 billion, a P/E ratio of 43.08, a PEG ratio of 2.20 and a beta of 0.65.

Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Friday, November 6th. The insurance provider reported ($0.70) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.00) by $0.30. Humana had a net margin of 0.81% and a return on equity of 8.50%. The firm had revenue of $41.16 billion for the quarter, compared to analysts’ expectations of $40.87 billion. During the same period in the prior year, the company earned $3.24 EPS. The business’s revenue was up 26.1% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.500- EPS. On average, analysts expect that Humana will post 9.66 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 24th will be issued a dividend of $0.8850 per share. This represents a $3.54 annualized dividend and a yield of 0.8%. The ex-dividend date is Thursday, December 24th. Humana’s dividend payout ratio is presently 34.44%.

About Humana

(Get Free Report)

Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

Further Reading

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.